Amyloid plaque and neurofibrillary tangle pathology in a regulatable mouse model of Alzheimer's disease. - Wikidata - awgldk - TriplyDB

Amyloid plaque and neurofibrillary tangle pathology in a regulatable mouse model of Alzheimer's disease.

Amyloid plaque and neurofibrillary tangle pathology in a regulatable mouse model of Alzheimer's disease.

http://www.wikidata.org/entity/Q36855702

about

An overview on therapeutics attenuating amyloid β level in Alzheimer's disease: targeting neurotransmission, inflammation, oxidative stress and enhanced cholesterol levels In vivo characterization of a bigenic fluorescent mouse model of Alzheimer's disease with neurodegeneration Effect size of memory deficits in mice with adult-onset P301L tau expression.Characterization of a Novel Mouse Model of Alzheimer's Disease--Amyloid Pathology and Unique β-Amyloid Oligomer Profile.Quaternary Structure Defines a Large Class of Amyloid-β Oligomers Neutralized by Sequestration.Transgenic APP expression during postnatal development causes persistent locomotor hyperactivity in the adult.Riluzole rescues glutamate alterations, cognitive deficits, and tau pathology associated with P301L tau expression Molecular Signaling Mechanisms of Natural and Synthetic Retinoids for Inhibition of Pathogenesis in Alzheimer's Disease.Riluzole rescues alterations in rapid glutamate transients in the hippocampus of rTg4510 mice.Beta 2-adrenergic receptor activation enhances neurogenesis in Alzheimer's disease mice.Hyperbaric Oxygen and Ginkgo Biloba Extract Ameliorate Cognitive and Memory Impairment via Nuclear Factor Kappa-B Pathway in Rat Model of Alzheimer's Disease.Amyloid precursor protein and tau transgenic models of Alzheimer's disease: insights from the past and directions for the future Regulation of IL-1β-induced cyclooxygenase-2 expression by interactions of Aβ peptide, apolipoprotein E and nitric oxide in human neuroglioma.Humanin attenuates Alzheimer-like cognitive deficits and pathological changes induced by amyloid β-peptide in rats Thrombospondin-1 secreted by human umbilical cord blood-derived mesenchymal stem cells rescues neurons from synaptic dysfunction in Alzheimer's disease model.Neurofibrillary tangle formation by introducing wild-type human tau into APP transgenic mice.Senile Dementia from Neuroscientific and Islamic Perspectives.Deciphering the Biochemical Pathway and Pharmacokinetic Study of Amyloid βeta-42 with Superparamagnetic Iron Oxide Nanoparticles (SPIONs) Using Systems Biology Approach.A variant within FGF1 is associated with Alzheimer's disease in the Han Chinese population.Modulation of the ATP-Binding Cassette B1 Transporter by Neuro-Inflammatory Cytokines: Role in the Pathogenesis of Alzheimer's Disease.

P2860

Q26751302-9CB757B9-FE06-48BB-807F-1089E39D0DFB Q34050850-53B13BDB-8D41-46CB-AA5A-55C3CEB970BA Q34117765-B2035BA7-432B-4771-A8A9-6FF279DA915D Q35577702-E00AD404-C944-4652-9DC9-226D92C6F278 Q35826425-B8A9C4C1-D193-412D-81BD-CD220210C2E1 Q36278646-4F6F24B3-A742-4472-8BBD-0BB2D127364F Q36475830-4D233DE5-CFC3-4AA7-9861-7923FC00C413 Q36771721-7DC22B0B-C896-4CC9-9B21-A0DE7502A089 Q36892828-8C629DE7-475F-459E-9293-8EFF82B6BFA9 Q37425227-C0E7DEE5-EFAE-4D12-9354-10033C05FF97 Q39081187-E6EDBB88-E4EF-4075-8E2B-1DCB1D8B5520 Q39420600-B2793E99-4C8F-4B12-BDC5-4484DD13BBD7 Q39439875-8A10D40B-B0B2-44C2-9DCE-4429BA0F5C73 Q41457813-057E9792-039F-4086-94A3-2EAF3796156E Q49367941-07C35492-7D94-4647-8F48-2E4B7718FB58 Q50860536-660A4907-C8D6-4341-9B99-42C09F6199F9 Q50885299-91AD0E50-7373-45A0-AB46-8257BA45B153 Q50886075-76C5D607-1472-439C-A1DA-49B5F8877B76 Q53348503-DC4BEA44-8CB8-4316-BAF6-B0F4A8E6D9CA Q55404360-372BFDF6-3FE0-4432-AE48-589A28774D68

P2860

Amyloid plaque and neurofibrillary tangle pathology in a regulatable mouse model of Alzheimer's disease.

http://www.wikidata.org/entity/Q36855702

description

2008 nî lūn-bûn

@nan

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

2008年论文

@zh

2008年论文

@zh-cn

name

Amyloid plaque and neurofibril ...... model of Alzheimer's disease.

@en

type

label

Amyloid plaque and neurofibril ...... model of Alzheimer's disease.

@en

prefLabel

Amyloid plaque and neurofibril ...... model of Alzheimer's disease.

@en

P1433

Q36855702-05B7B8CB-9090-4810-A812-20320E059337

P1476

Q36855702-6D664FB9-4A1D-413F-8A3B-7CC6245363D0

P2093

Q36855702-392E79DF-46AC-4003-911E-EF7F54EB1C97

Q36855702-4F56700A-43BC-424B-8A85-FFB8F2A3F095

Q36855702-8F6C7F58-CCC9-4030-92A9-8C8BF8EB9E6E

Q36855702-B471487D-55CD-4E66-AC57-C9939FB0FED0

Q36855702-D8108D6F-A240-4295-A928-D2AEC0EA9832

Q36855702-FF181740-80C5-4595-B4C4-22A45E94CA48

P2860

Q36855702-00D8B235-4365-4CF6-BC53-C2FDA81CDCE6

Q36855702-0283171A-DC4B-4D35-A676-0225BB3FF62D

Q36855702-07DB9936-4180-43EB-B8C9-EC2DC252C367

Q36855702-124D3C62-B274-42F6-B593-8B6A2E0842AB

Q36855702-12E992C6-C2B9-4A22-85E7-5796C8A161DF

Q36855702-20263143-021F-4DEF-A36F-A9513C2090FF

Q36855702-293A38D2-C76E-4372-AEEC-F91160550BE5

Q36855702-2B4A11B0-FDB4-4ED9-A9A0-70A61F6B4485

Q36855702-31ADA264-B693-4A6D-82EA-A0B830625797

Q36855702-34513630-A402-4C8D-AA63-B066532A5A3F

P304

Q36855702-9C838715-95B6-44FD-A1B5-6514A178F10B

P31

Q36855702-F2B9F49E-D9F0-4A76-973D-E13BA883C7A7

P356

Q36855702-1B77EFA0-4A92-446D-916E-BB8F31FE6C78

P407

Q36855702-500001CC-89A5-4D1E-9446-5F39AEACA744

P433

Q36855702-8CAE47F0-85FA-4BC3-B723-FBCA58D06E93

P478

Q36855702-532FB6ED-343C-4A19-83E1-BA9E0834E9EC

P577

Q36855702-760D63B0-B8DC-4930-B25C-CA9C4730BB8B

P5875

Q36855702-0BF9D349-56C9-43D5-8758-8DC7CAA49C69

P698

Q36855702-A11E7B11-0D4F-47FA-B389-0F022CF44711

P932

Q36855702-FC5A4D4F-FC7E-494C-B134-28728F4020FE

P356

AJPATH.2008.080175

P1433

The American Journal of Pathology

P1476

Amyloid plaque and neurofibril ...... model of Alzheimer's disease.

@en

P2093

Colleen Forster

http://www.w3.org/2001/XMLSchema#string

Eileen McGowan

http://www.w3.org/2001/XMLSchema#string

Jennifer B Paulson

http://www.w3.org/2001/XMLSchema#string

Karen H Ashe

http://www.w3.org/2001/XMLSchema#string

Martin Ramsden

http://www.w3.org/2001/XMLSchema#string

Mathew A Sherman

http://www.w3.org/2001/XMLSchema#string

P2860

Persistent amyloidosis following suppression of Abeta production in a transgenic model of Alzheimer disease

Correlative Memory Deficits, Abeta Elevation, and Amyloid Plaques in Transgenic Mice

Tight control of gene expression in mammalian cells by tetracycline-responsive promoters

Induction of tau pathology by intracerebral infusion of amyloid-beta -containing brain extract and by amyloid-beta deposition in APP x Tau transgenic mice

Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivo

Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease

Globular amyloid beta-peptide oligomer - a homogenous and stable neuropathological protein in Alzheimer's disease

Association of missense and 5'-splice-site mutations in tau with the inherited dementia FTDP-17

A specific amyloid-beta protein assembly in the brain impairs memory

Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins

P304

762-772

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2353/AJPATH.2008.080175

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

173

http://www.w3.org/2001/XMLSchema#string

P577

2008-07-31T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

23139967

http://www.w3.org/2001/XMLSchema#string

P698

18669616

http://www.w3.org/2001/XMLSchema#string

P932

2527075

http://www.w3.org/2001/XMLSchema#string